| Drug Type Gene therapy | 
| Synonyms GNE Lipoplex, Hereditary inclusion body myopathy gene therapy | 
| Target | 
| Action- | 
| Mechanism GNE gene transference | 
| Therapeutic Areas | 
| Active Indication- | 
| Inactive Indication | 
| Originator Organization | 
| Active Organization- | 
| Inactive Organization | 
| License Organization- | 
| Drug Highest PhasePendingPhase 1 | 
| First Approval Date- | 
| RegulationOrphan Drug (United States) | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Distal Myopathies | Phase 1 | - | - | |
| Distal Myopathy, Nonaka Type | Phase 1 | United States  | - | 
| Not Applicable | - | wvxylihcoo(vthsoqhvji) = xcejskwryc xzqlbjdknw (gqdhgmbrur ) | - | 01 May 2010 | 





